Clinical Trial: Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis

U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07277179) titled 'Evaluate the Efficacy, Safety, and Pharmacokinetic Profile and Immunogenicity of Subcutaneous Netakimab in Chinese Adult Patients With Active Ankylosing Spondylitis' on Nov. 30.

Brief Summary: The goal of this clinical trial is to To evaluate the efficacy of subcutaneous (SC) Netakimab in adult Chinese patients with Active Ankylosing Spondylitis. Researchers will compare Netakimab to placebo to see if Netakimab works to treat Ankylosing Spondylitis.

Study Start Date: March 20, 2023

Study Type: INTERVENTIONAL

Condition: Ankylosing Spondylitis

Intervention: DRUG: Netakimab

Netakimab administered subcutaneously

DRUG: Placebo

P...